CT-2103 [polyglutamate paclitaxel]/carboplatin vs paclitaxel/carboplatin for the treatment of PS = 2 patients with chemotherapy naive advanced non-small cell lung cancer (NSCLC): a phase III study

Trial Profile

CT-2103 [polyglutamate paclitaxel]/carboplatin vs paclitaxel/carboplatin for the treatment of PS = 2 patients with chemotherapy naive advanced non-small cell lung cancer (NSCLC): a phase III study

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 25 Jul 2014

At a glance

  • Drugs Carboplatin; Paclitaxel; Paclitaxel poliglumex
  • Indications Non-small cell lung cancer
  • Focus Registrational; Therapeutic Use
  • Acronyms STELLAR-3
  • Sponsors CTI BioPharma
  • Most Recent Events

    • 01 Jun 2008 Results have been published
    • 02 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top